DR. HOENLE AG O.N./ DE0005157101 /
26/04/2024 17:36:20 | Diferencia 0.000 | Volumen | Bid26/04/2024 | Ask26/04/2024 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
19.900EUR | 0.00% | 1,951 Volumen de negocios: 38,619.700 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 119.44 millonesEUR | 1.12% | - |
Newsfile Corp
3:20
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Che...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocu...
GlobeNewswire
2:40
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Exscientia plc with Losses to ...
GlobeNewswire
2:17
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with L...
Newsfile Corp
1:11
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Se...
Newsfile Corp
28/04
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Befor...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página